Skip to main content

Prelude Therapeutics Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Prelude Therapeutics Inc

Did you know?

Holds 2.2x more cash than debt — a strong balance sheet.

Current Price

$4.74

+0.85%

GoodMoat Value

$0.97

79.6% overvalued
Profile
Valuation (TTM)
Market Cap$297.98M
P/E-2.99
EV
P/B4.34
Shares Out62.87M
P/Sales24.55
Revenue$12.14M
EV/EBITDA

Prelude Therapeutics Inc (PRLD) Insider Trades

PRLD Insider Trading Activity

Track insider trading transactions for Prelude Therapeutics Inc (PRLD). Monitor recent buys, sells, and option exercises by officers, directors, and 10% beneficial owners. Insider trading activity can signal management confidence or concern about a stock's future prospects.

Current stock price: $4.74. Market cap: $297.98M. This page displays the most recent insider transactions for PRLD, including the insider's name, title, transaction type (purchase, sale, or option exercise), number of shares, and total value. Filter transactions by type to focus on open-market purchases or sales.

Insider buying is often viewed as a bullish signal, as insiders are putting their own capital at risk. Conversely, large insider sales may warrant further investigation. Use GoodMoat's insider trading data alongside financial analysis, quality scores, and valuation tools for a comprehensive view of Prelude Therapeutics Inc's investment outlook.